So joining me now in a first on CNBC interview is Ela Co. Animal Health CEO Jeff Simmons. Jeff, we've spoken numerous times before.At this point, you know, I have multiple dogs in my household. Like many millions of Americans, we care about their health. What's been driving Ela Co's results, specifically when it comes to the pets versus the farm side of things.>> Yeah, Dom, thanks for the time. Yeah, we delivered a great quarter. 9% organic constant currency growth.That really marks uh nine consecutive quar ...

Core Insights - Ela Co. Animal Health reported a 9% organic constant currency growth, marking nine consecutive quarters of growth, driven by both pet and livestock segments [1][2] - The company experienced its highest quality quarter of growth in three to four years, attributed to innovation in pet health products and strong demand in the livestock sector [3][4] Pet Segment - Pet owners are increasingly willing to spend on innovative health products, particularly in areas like dermatology and pain management for pets [3] - The company has a significant product, Credelo Quattro, which has rapidly gained traction, becoming the fastest product to reach $100 million in sales [7][8] Livestock Segment - The livestock market is benefiting from high protein demand, with the US beef market experiencing a shortage of cattle at a 50-year low, leading to strong beef economics [4] - The company is focusing on ruminant markets, including dairy, beef, and poultry, as key growth areas [9] Innovation and Product Pipeline - Ela Co. emphasizes innovation as the primary driver of growth, with a diverse portfolio across multiple species and therapeutic classes [6][7] - The company plans to discuss its strategies for the ruminant, poultry, and pet markets during an upcoming investor day [9]